Not all patients with CLL call for therapy. In spite of all modern advancements, the iwCLL still suggests watchful observation for clients with asymptomatic illness.86 This recommendation relies on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Each trials concluded https://lukaszrixo.blogadvize.com/39704979/link-alternatif-mbl77-secrets